Focus Partners Wealth’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,665
Closed -$226K 2784
2025
Q4
$226K Buy
+3,665
New +$224K ﹤0.01% 2390
2025
Q3
Sell
-3,148
Closed -$251K 2286
2025
Q2
$251K Buy
3,148
+119
+4% +$9.95K ﹤0.01% 1767
2025
Q1
$260K Buy
3,029
+14
+0.5% +$1.15K ﹤0.01% 1639
2024
Q4
$235K Buy
+3,015
New +$234K ﹤0.01% 1659

Other funds holding PBH

Focus Partners Wealth's PBH Position: Q1 2026 in Review

Focus Partners Wealth sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 3,665 shares — an estimated $226K sold.

Focus Partners Wealth first reported a position in PBH in Q4 2024 and held it in 4 quarters. The position peaked at $260K in Q1 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Focus Partners Wealth reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Focus Partners Wealth sold 3,665 Prestige Consumer Healthcare shares in Q1 2026, an estimated $226K.
  • Focus Partners Wealth first reported a position in Prestige Consumer Healthcare in Q4 2024 and held it in 4 quarters.
  • Focus Partners Wealth's Prestige Consumer Healthcare position peaked at $260K in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.